3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome

Lina S Correa-Cerro; Forbes D Porter

doi:10.1016/j.ymgme.2004.09.017

3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome

Mol Genet Metab. 2005 Feb;84(2):112-26. doi: 10.1016/j.ymgme.2004.09.017. Epub 2004 Dec 19.

Authors

Lina S Correa-Cerro¹, Forbes D Porter

Affiliation

¹ Unit on Molecular Dysmorphology, Heritable Disorders Branch, Department of Health and Human Services, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

PMID: 15670717
DOI: 10.1016/j.ymgme.2004.09.017

Abstract

In the final step of cholesterol synthesis, 7-dehydrocholesterol reductase (DHCR7) reduces the double bond at C7-8 of 7-dehydrocholesterol to yield cholesterol. Mutations of DHCR7 cause Smith-Lemli-Opitz syndrome (SLOS). Over 100 different mutations of DHCR7 have been identified in SLOS patients. SLOS is a classical multiple malformation, mental retardation syndrome, and was the first human malformation syndrome shown to result from an inborn error of cholesterol synthesis. This paper reviews the biochemical, molecular, and mutational aspects of DHCR7.

Publication types

Research Support, U.S. Gov't, P.H.S.
Review

MeSH terms

Amino Acid Sequence
Humans
Molecular Sequence Data
Mutation
Oxidoreductases Acting on CH-CH Group Donors / genetics*
Sequence Homology, Amino Acid
Smith-Lemli-Opitz Syndrome / enzymology*
Smith-Lemli-Opitz Syndrome / genetics

Substances

Oxidoreductases Acting on CH-CH Group Donors
7-dehydrocholesterol reductase

Associated data

OMIM/251170
OMIM/260920